Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Mar 10;72(10):265-267.
doi: 10.15585/mmwr.mm7210a4.

Notes from the Field: Increase in Pediatric Invasive Group A Streptococcus Infections - Colorado and Minnesota, October-December 2022

Notes from the Field: Increase in Pediatric Invasive Group A Streptococcus Infections - Colorado and Minnesota, October-December 2022

Meghan Barnes et al. MMWR Morb Mortal Wkly Rep. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. Ruth Lynfield reports participation on the Council of State and Territorial Epidemiologists (CSTE) Executive Board, the National Foundation of Infectious Diseases (NFID) Executive Board, the Program Committee for ID Week, and serving as associate editor of the American Academy of Pediatrics Red Book (the fee for which was donated to the Minnesota Department of Health), and receipt of support from these groups to attend CSTE, American Academy of Pediatrics Committee on Infectious Diseases, NFID, and ID Week meetings. Samuel R. Dominguez reports institutional support from Pfizer and Biofire Diagnostics, unrelated to the current work, and consulting fees (paid to his institution) from Biofire Diagnostics and Karius. Jennifer Zipprich reports that her spouse is employed by Pfizer. No other potential conflicts of interest were disclosed.

Figures

FIGURE
FIGURE
Cases of invasive group A Streptococcus infections and hospitalization rates for influenza and respiratory syncytial virus among children and adolescents aged <18 years — Colorado and Minnesota, January 2016–December 2022 Abbreviations: iGAS = invasive group A Streptococcus infection; RSV = respiratory syncytial virus. * iGAS infections were identified through each state’s Emerging Infections Program Active Bacterial Core surveillance systems. Cases in Colorado are from the Denver metropolitan area; cases in Minnesota throughout the state are reportable to the Minnesota Department of Health. Hospitalizations per 100,000 population. § Colorado influenza hospitalizations are reported from the Denver metropolitan area, and rates in children and adolescents aged <18 years were calculated using age-specific and geographically defined population data obtained from the Colorado Department of Local Affairs, Demography Office. Influenza hospitalizations in Minnesota throughout the state are reportable to the Minnesota Department of Health; Minnesota influenza hospitalization rates in children and adolescents aged <18 years were calculated using age-specific and statewide population data obtained from CDC WONDER. RSV hospitalizations in Colorado were from the Denver metropolitan area; RSV hospitalization rates in children and adolescents aged <18 years were calculated using age-specific and Denver metropolitan population data obtained from the Colorado Department of Local Affairs, Demography Office. Colorado RSV hospitalization data are available during July 2019–December 2022. Minnesota RSV hospitalization rates are from the seven-county Twin Cities metropolitan area; rates in children and adolescents aged <18 years were calculated using age-specific and seven-county metropolitan population data obtained from CDC WONDER. Minnesota RSV hospitalization data were available during October 2018–December 2022. ** COVID-19 cases were not included because of the short period for which data were available and the variations in testing practices and surveillance catchment areas that limit the comparability of data.

References

    1. Prasad N, Rhodes J, Deng L, et al. Changes in the incidence of invasive bacterial disease during the COVID-19 pandemic in the United States, 2014–2020. J Infect Dis 2023. Epub February 1, 2023. 10.1093/infdis/jiad028 - DOI - PMC - PubMed
    1. Herrera AL, Huber VC, Chaussee MS. The association between invasive group A streptococcal diseases and viral respiratory tract infections. Front Microbiol 2016;7:342. 10.3389/fmicb.2016.00342 - DOI - PMC - PubMed
    1. Fay K, Onukwube J, Chochua S, et al. Patterns of antibiotic nonsusceptibility among invasive group A Streptococcus infections—United States, 2006–2017. Clin Infect Dis 2021;73:1957–64. 10.1093/cid/ciab575 - DOI - PubMed
    1. Lewnard JA, Whittles LK, Rick AM, Martin JM. Naturally acquired protection against upper respiratory symptoms involving group A Streptococcus in a longitudinal cohort study. Clin Infect Dis 2020;71:e244–54. 10.1093/cid/ciaa044 - DOI - PMC - PubMed
    1. Hasin O, Hazan G, Rokney A, et al. Invasive group A Streptococcus infection in children in southern Israel before and after the introduction of varicella vaccine. J Pediatric Infect Dis Soc 2020;9:236–9. 10.1093/jpids/piz013 - DOI - PubMed